About Pahr Therapeutics
Pahr Therapeutics is a private company based in Boston, Massachusetts, incorporated in 2025 in Delaware. It has reported $4,666,668 raised in one offering on Form D since July 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 27, 2025 | Jul 18, 2025 | $4,666,668of $14.0M target | 4 | $1.1M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pahr Therapeutics's Form D filed Jul 18, 2025.
AU
Atsushi Usami
Director
AL
Andrew Levin
Director
KH
Ken Horne
Director
Also a chief executive officer and director at Capacity Bio and a director at Imbria Pharmaceuticals and Typewriter Therapeutics.
NB
Neil Buckley
President and director
AC
Amanda Creedon
Executive officer